Monoclonal Antibodies as Treatment for Multiple Myeloma

Monoclonal Antibodies

Module

Monoclonal Antibodies as Treatment for Multiple Myeloma

nurse-showing-elderly-patient-results-mobile-device

Description:

Learn how monoclonal antibodies can help a myeloma patient’s immune system to recognize and destroy cancer cells.

Module Objectives:

Review important information on FDA-approved monoclonal antibody therapies in myeloma
Define relevant nursing considerations when treating myeloma patients with monoclonal antibodies

Instructor:

Donna Catamero, ANP-BC, OCN, CCRC

Additional Resources:

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Learn practical strategies to recognize, monitor, and manage cytokine release syndrome (CRS), neurotoxicity (ICANS), and infection risk associated with bispecific antibody therapy in multiple myeloma, with an emphasis on patient safety and care coordination.

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module

VIEW ALL MODULES

CAR T Therapy in Multiple Myeloma

Car T Therapy, Module

Module

CAR-T Therapy in Multiple Myeloma

Description:

A discussion of the patient journey and CAR-T therapy management in multiple myeloma.

Module Objectives:

Learn about the effectiveness of CAR-T therapy
Define the patient journey and common processes of CAR-T therapy
Prepare patients and practitioners for common adverse events of this treatment

Instructor:

Donna Catamero, ANP-BC, OCN, CCRC

Additional Resources:

Ide-cel, a Novel CAR-T in Multiple Myeloma Patients: Recognition and Management of Short Term and Long Term Adverse Events

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module

Managing CRS, Neurotoxicity, and Infection

Start Module

Transitions of Care

Learn about transitions of care in multiple myeloma, emphasizing the importance of coordinated communication.

Start Module

Survivorship and Self Management

Learn about survivorship and self management strategies for multiple myeloma patients

Start Module

Bispecifics in Multiple Myeloma

Learn about the use of bispecific treatments in multiple myeloma

Start Module

Renal Impairment

An overview of nursing considerations for myeloma patients with renal impairment, including the role of dose modifications

Start Module

CAR-T Therapy

An exciting novel treatment for patients with myeloma

Start Module

Monoclonal Antibodies

Using the patient’s own immune system to destroy myeloma cells.

Start Module

How Treatments Are Selected

Is treatment working? An overview of myeloma treatment history and management over the course of the disease.

Start Module

Myeloma Treatments - Part 1

An overview of myeloma treatments: Steroids, IMiDs, and PIs

Start Module

Myeloma Treatments - Part 2

Review newer drugs used to treat multiple myeloma in a relapse setting: selinexor, and venetoclax.

Start Module

Autologous Stem Cell Transplant (ASCT) for Treatment of Multiple Myeloma

High-level overview of autologous stem cell transplant (ASCT) for treatment of multiple myeloma.

Start Module

VIEW ALL MODULES

Renal Impairment in Multiple Myeloma

Module, Renal Impairment

Module

Renal Impairment in Multiple Myeloma

Description:
Learn about renal (kidney) impairment in patients with multiple myeloma.

Module Objectives:

Review important concepts for patients with myeloma and renal impairment
Highlight important nursing considerations for patient education
Reinforce the importance of dose modifications in medications for patients with renal impairment

Instructor:
Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN

Additional Resources:

Modules

Managing BCMA Bispecifics in the Community

This module equips oncology nurses with practical strategies to safely initiate, monitor, and manage BCMA‑targeted bispecific antibodies for multiple myeloma in community practice settings.

Start Module